Skip to content
10-Q

Quarterly Report

ENDOCYTE INC

0001558370-18-008940

← back to feed
Filed
Nov 8, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2018 · Oct 26, 2018 82.09M sh
Stock Repurchased Q3 2018 · Sep 30, 2018 $104.46K
Stock Repurchased Q3 2018 · Sep 30, 2017 $94.63K
Capex Q3 2018 · Sep 30, 2018 $43.09K
Capex Q3 2018 · Sep 30, 2017 $46.83K
Operating Cash Flow Q3 2018 · Sep 30, 2018 −$34.29M
Operating Cash Flow Q3 2018 · Sep 30, 2017 −$27.41M
Cash And Equivalents Q3 2018 · Sep 30, 2018 $67.27M
Cash And Equivalents Q3 2018 · Dec 31, 2017 $18.56M
Stockholders Equity Q3 2018 · Sep 30, 2018 $347.2M
Stockholders Equity Q3 2018 · Dec 31, 2017 $95.48M
Current Liabilities Q3 2018 · Sep 30, 2018 $7.67M
Current Liabilities Q3 2018 · Dec 31, 2017 $4.55M
Total Liabilities Q3 2018 · Sep 30, 2018 $8.01M
Total Liabilities Q3 2018 · Dec 31, 2017 $5.28M
Current Assets Q3 2018 · Sep 30, 2018 $351.31M
Current Assets Q3 2018 · Dec 31, 2017 $98.57M
Total Assets Q3 2018 · Sep 30, 2018 $355.2M
Total Assets Q3 2018 · Dec 31, 2017 $100.76M
Sga Expense Q3 2018 · Sep 30, 2018 $4.79M
Sga Expense Q3 2018 · Sep 30, 2018 $13.2M
Sga Expense Q3 2018 · Sep 30, 2017 $3.01M
Sga Expense Q3 2018 · Sep 30, 2017 $10.06M
Rd Expense Q3 2018 · Sep 30, 2018 $8.86M
Rd Expense Q3 2018 · Sep 30, 2018 $21.74M
Rd Expense Q3 2018 · Sep 30, 2017 $4.09M
Rd Expense Q3 2018 · Sep 30, 2017 $20.74M
Net Income Q3 2018 · Sep 30, 2018 −$12.61M
Net Income Q3 2018 · Sep 30, 2018 −$32.77M
Net Income Q3 2018 · Sep 30, 2017 −$23.27M
Net Income Q3 2018 · Sep 30, 2017 −$46.5M
Operating Income Q3 2018 · Sep 30, 2018 −$13.56M
Operating Income Q3 2018 · Sep 30, 2018 −$34.82M
Operating Income Q3 2018 · Sep 30, 2017 −$23.56M
Operating Income Q3 2018 · Sep 30, 2017 −$47.24M